Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Federico De Marchi
Concomitant Monitoring ofWT1andFLT3-ITDexpression inFLT3-ITDacute Myeloid Leukemia Patients: Which Should We Trust as a Minimal Residual Disease Marker?
American Journal of Hematology
Hematology
Related publications
Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Plasma-Derived Exosomes in Acute Myeloid Leukemia for Detection of Minimal Residual Disease: Are We Ready?
Expert Review of Molecular Diagnostics
Forensic Medicine
Genetics
Pathology
Molecular Medicine
Molecular Biology
Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?
Journal of Clinical Medicine
Monitoring of Minimal Residual Disease in Adult Acute Myeloid Leukemia Using Peripheral Blood as an Alternative Source to Bone Marrow
Haematologica
Hematology
Estimation of Molecular Upper Remission Limit for Monitoring Minimal Residual Disease in Peripheral Blood of Acute Myeloid Leukemia Patients by WT1 Expression
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
FLT3 as a Marker of Minimal Residual Disease: Time to Re-Think?
American Journal of Hematology
Hematology
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
Serological Normalisation as a Surrogate Marker for Minimal Residual Disease Negativity in Multiple Myeloma
British Journal of Haematology
Hematology
Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
